Search Results - "Kim, Hawk"

Age and remission induction therapy for acute myeloid leukemia: An analysis of data from the Korean acute myeloid leukemia registry by Yoo, Kwai Han, Kim, Hyeoung-Joon, Min, Yoo Hong, Hong, Dae-Sik, Lee, Won Sik, Kim, Hee-Je, Shin, Ho-Jin, Park, Yong, Lee, Je-Hwan, Kim, Hawk

“…The clinical characteristics and therapeutic strategy in acute myeloid leukemia (AML) are influenced by patients' age. We evaluated the impact of age on…”
Get full text

Imatinib withdrawal syndrome and longer duration of imatinib have a close association with a lower molecular relapse after treatment discontinuation: the KID study by Lee, Sung-Eun, Choi, Soo Young, Song, Hye-Young, Kim, Soo-Hyun, Choi, Mi-Yeon, Park, Joon Seong, Kim, Hyeoung-Joon, Kim, Sung-Hyun, Zang, Dae Young, Oh, Sukjoong, Kim, Hawk, Do, Young Rok, Kwak, Jae-Yong, Kim, Jeong-A, Kim, Dae-Young, Mun, Yeung-Chul, Lee, Won Sik, Chang, Myung Hee, Park, Jinny, Kwon, Ji Hyun, Kim, Dong-Wook

“…The aim of the Korean Imatinib Discontinuation Study was to identify predictors for safe and successful imatinib discontinuation. A total of 90 patients with a…”
Get full text

Author Correction: Targeting c-KIT (CD117) by dasatinib and radotinib promotes acute myeloid leukemia cell death by Heo, Sook-Kyoung, Noh, Eui-Kyu, Kim, Jeong Yi, Jeong, Yoo Kyung, Jo, Jae-Cheol, Choi, Yunsuk, Koh, SuJin, Baek, Jin Ho, Min, Young Joo, Kim, Hawk

Get full text

Outcomes of decitabine treatment for newly diagnosed acute myeloid leukemia in older adults by Yoo, Kwai Han, Cho, Jinhyun, Han, Boram, Kim, Se Hyung, Shin, Dong-Yeop, Hong, Junshik, Kim, Hawk, Kim, Hyo Jung, Zang, Dae Young, Yoon, Sung-Soo, Jin, Jong-Youl, Lee, Jae Hoon, Hong, Dae-Sik, Park, Seong Kyu

“…We evaluated the outcomes of decitabine as first-line treatment in older patients with acute myeloid leukemia (AML) and investigated the predictors, including…”
Get full text

Low-dose abdominopelvic computed tomography in patients with lymphoma: An image quality and radiation dose reduction study by Yoon, Sungjin, Yoo, Kwai Han, Park, So Hyun, Kim, Hawk, Lee, Jae Hoon, Park, Jinny, Park, Seong Ho, Kim, Hwa Jung

“…This study aimed to evaluate image quality, the detection rate of enlarged lymph nodes, and radiation dose exposure of ultralow-dose and low-dose…”
Get full text

Phase III Clinical Trial (RERISE study) Results of Efficacy and Safety of Radotinib Compared with Imatinib in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia by Kwak, Jae-Yong, Kim, Sung-Hyun, Oh, Suk Joong, Zang, Dae Young, Kim, Hawk, Kim, Jeong-A, Do, Young Rok, Kim, Hyeoung Joon, Park, Joon Seong, Choi, Chul Won, Lee, Won Sik, Mun, Yeung-Chul, Kong, Jee Hyun, Chung, Joo Seop, Shin, Ho-Jin, Kim, Dae-Young, Park, Jinny, Jung, Chul Won, Bunworasate, Udomsak, Comia, Narcisa Sonia, Jootar, Saengsuree, Reksodiputro, Arry Harryanto, Caguioa, Priscilla B, Lee, Sung-Eun, Kim, Dong-Wook

“…Radotinib is a second-generation BCR-ABL1 tyrosine kinase inhibitor (TKI) approved in Korea for chronic phase chronic myeloid leukemia (CML-CP) in patients…”
Get full text

LIGHT (TNFSF14) Increases the Survival and Proliferation of Human Bone Marrow-Derived Mesenchymal Stem Cells by Heo, Sook-Kyoung, Noh, Eui-Kyu, Gwon, Gi-Dong, Kim, Jeong Yi, Jo, Jae-Cheol, Choi, Yunsuk, Koh, SuJin, Baek, Jin Ho, Min, Young Joo, Kim, Hawk

“…LIGHT (HVEM-L, TNFSF14, or CD258), an entity homologous to lymphotoxins, with inducible nature and the ability to compete with herpes simplex virus…”
Get full text

Targeting c-KIT (CD117) by dasatinib and radotinib promotes acute myeloid leukemia cell death by Heo, Sook-Kyoung, Noh, Eui-Kyu, Kim, Jeong Yi, Jeong, Yoo Kyung, Jo, Jae-Cheol, Choi, Yunsuk, Koh, SuJin, Baek, Jin Ho, Min, Young Joo, Kim, Hawk

“…Dasatinib and radotinib are oral BCR-ABL tyrosine kinase inhibitors that were developed as drugs for the treatment of chronic myeloid leukemia. We report here…”
Get full text

Autologous hematopoietic cell transplantation following high-dose cytarabine consolidation for core-binding factor-acute myeloid leukemia in first complete remission: a phase 2 prospective trial by Choi, Eun-Ji, Lee, Je-Hwan, Kim, Hawk, Choi, Yunsuk, Lee, Won-Sik, Lee, Sang-Min, Park, Jun-Hong, Park, Han-Seung, Lee, Jung-Hee, Lee, Kyoo-Hyung

“…Core-binding factor (CBF)-acute myeloid leukemia (AML) generally have a favorable prognosis. However, approximately 50% of patients experience disease relapse…”
Get full text

Long‐term data from a phase 3 study of radotinib versus imatinib in patients with newly diagnosed, chronic myeloid leukaemia in the chronic phase (RERISE) by Do, Young Rok, Kwak, Jae‐Yong, Kim, Jeong A., Kim, Hyeoung Joon, Chung, Joo Seop, Shin, Ho‐Jin, Kim, Sung‐Hyun, Bunworasate, Udomsak, Choi, Chul Won, Zang, Dae Young, Oh, Suk Joong, Jootar, Saengsuree, Reksodiputro, Ary Harryanto, Lee, Won Sik, Mun, Yeung‐Chul, Kong, Jee Hyun, Caguioa, Priscilla B., Kim, Hawk, Park, Jinny, Kim, Dong‐Wook

“…Summary In the phase 3 study RERISE, patients with newly diagnosed chronic myeloid leukaemia in chronic phase demonstrated significantly faster and higher…”
Get full text

Prospective randomized trial comparing two doses of rabbit anti‐thymocyte globulin in patients with severe aplastic anaemia by Narita, Atsushi, Zhu, Xiaofan, Muramatsu, Hideki, Chen, Xiaojuan, Guo, Ye, Yang, Wenyu, Zhang, Jingliao, Liu, Fang, Jang, Jun H., Kook, Hoon, Kim, Hawk, Usuki, Kensuke, Yamazaki, Hirohito, Takahashi, Yoshiyuki, Nakao, Shinji, Wook Lee, Jong, Kojima, Seiji

“…Summary The treatment of choice for patients with severe aplastic anaemia (SAA) includes immunosuppressive therapy (IST) with anti‐thymocyte globulin (ATG) and…”
Get full text

Dasatinib accelerates valproic acid-induced acute myeloid leukemia cell death by regulation of differentiation capacity by Heo, Sook-Kyoung, Noh, Eui-Kyu, Yoon, Dong-Joon, Jo, Jae-Cheol, Park, Jae-Hoo, Kim, Hawk

“…Dasatinib is a compound developed for chronic myeloid leukemia as a multi-targeted kinase inhibitor against wild-type BCR-ABL and SRC family kinases. Valproic…”
Get full text

Radotinib Induces Apoptosis of CD11b+ Cells Differentiated from Acute Myeloid Leukemia Cells by Heo, Sook-Kyoung, Noh, Eui-Kyu, Yoon, Dong-Joon, Jo, Jae-Cheol, Choi, Yunsuk, Koh, SuJin, Baek, Jin Ho, Park, Jae-Hoo, Min, Young Joo, Kim, Hawk

“…Radotinib, developed as a BCR/ABL tyrosine kinase inhibitor (TKI), is approved for the second-line treatment of chronic myeloid leukemia (CML) in South Korea…”
Get full text

Randomized Trial of Myeloablative Conditioning Regimens: Busulfan Plus Cyclophosphamide Versus Busulfan Plus Fludarabine by LEE, Je-Hwan, JOO, Young-Don, SOO HYUN, Myung, KIM, Dae-Young, KIM, Sung-Doo, JOO MIN, Young, LEE, Kyoo-Hyung, KIM, Hawk, MO RYOO, Hun, KYOUNG KIM, Min, LEE, Gyeong-Won, LEE, Jung-Hee, LEE, Won-Sik, PARK, Jae-Hoo, BAE, Sung-Hwa

“…We conducted a phase III randomized clinical trial to compare two myeloablative conditioning regimens for allogeneic hematopoietic cell transplantation (HCT)…”
Get full text

Molecular diagnosis of hereditary spherocytosis by multi-gene target sequencing in Korea: matching with osmotic fragility test and presence of spherocyte by Choi, Hyoung Soo, Choi, Qute, Kim, Jung-Ah, Im, Kyong Ok, Park, Si Nae, Park, Yoomi, Shin, Hee Young, Kang, Hyoung Jin, Kook, Hoon, Kim, Seon Young, Kim, Soo-Jeong, Kim, Inho, Kim, Ji Yoon, Kim, Hawk, Park, Kyung Duk, Park, Kyung Bae, Park, Meerim, Park, Sang Kyu, Park, Eun Sil, Park, Jeong-A, Park, Jun Eun, Park, Ji Kyoung, Baek, Hee Jo, Seo, Jeong Ho, Shim, Ye Jee, Ahn, Hyo Seop, Yoo, Keon Hee, Yoon, Hoi Soo, Won, Young-Woong, Lee, Kun Soo, Lee, Kwang Chul, Lee, Mee Jeong, Lee, Sun Ah, Lee, Jun Ah, Lee, Jae Min, Lee, Jae Hee, Lee, Ji Won, Lim, Young Tak, Jung, Hyun Joo, Chueh, Hee Won, Choi, Eun Jin, Jung, Hye Lim, Kim, Ju Han, Lee, Dong Soon

“…Current diagnostic tests for hereditary spherocytosis (HS) focus on the detection of hemolysis or indirectly assessing defects of membrane protein, whereas…”
Get full text

Trend and treatment patterns of aplastic anemia in Korea, pure red cell aplasia and myelodysplastic syndrome in Korea: a nation-wide analysis by Choi, Yunsuk, Jo, Jae-Cheol, Jeon, Hee-jeong, Kim, Dong Wook, Chang, Myung Hee, Kim, Hawk

“…Aplastic anemia (AA) and pure red cell aplasia (PRCA) appear to be more prevalent in Asian countries including Korea. However, there are no exact data…”
Get full text

Lenalidomide as a second‐line therapy after failure of hypomethylating agents in patients with myelodysplastic syndrome by Kim, Hawk, Lee, Je‐Hwan, Lee, Won‐Sik, Kim, Inho, Moon, Joon Ho, Choi, Chul Won, Lee, Ho Sup, Park, Jinny, Choi, Yunsuk, Shin, Ho‐Jin, Cho, Su‐Hee, Kim, Kyoung Ha, Kim, Sung‐Yong, Kim, Yoo‐Jin

Get full text

Efficacy and safety of radotinib in chronic phase chronic myeloid leukemia patients with resistance or intolerance to BCR-ABL1 tyrosine kinase inhibitors by Kim, Sung-Hyun, Menon, Hari, Jootar, Saengsuree, Saikia, Tapan, Kwak, Jae-Yong, Sohn, Sang-Kyun, Park, Joon Seong, Jeong, Seong Hyun, Kim, Hyeoung Joon, Kim, Yeo-Kyeoung, Oh, Suk Joong, Kim, Hawk, Zang, Dae Young, Chung, Joo Seop, Shin, Ho Jin, Do, Young Rok, Kim, Jeong-A, Kim, Dae-Young, Choi, Chul Won, Park, Sahee, Park, Hye Lin, Lee, Gong Yeal, Cho, Dae Jin, Shin, Jae Soo, Kim, Dong-Wook

“…Radotinib (IY5511HCL), a novel and selective BCR-ABL1 tyrosine kinase inhibitor, has shown pre-clinical and phase I activity and safety in chronic myeloid…”
Get full text

Real-world management of chronic myeloid leukemia in South Korea: the TARGET survey by Uhm, Jieun, Kim, Kyoung Ha, Lee, Hyewon, Kim, Hawk, Cassandra, Slader, Joo, Inkyung, Jung, Chul Won

“…The global TARGET survey examined real-world management of chronic myeloid leukemia (CML) compared with international guideline recommendations. This report…”
Get full text

Effect of BCR::ABL1 transcript type and droplet digital polymerase chain reaction on successful treatment-free remission in chronic myeloid leukemia patients who discontinued tyrosine kinase inhibitor by Park, Hyunkyung, Kim, Hyeong-Joon, Sohn, Sang-Kyun, Baik, Yoonsuk, Kim, Dongho, Lee, Sung-Yeoun, Kong, Jee Hyun, Kim, Hawk, Shin, Dong-Yeop, Ahn, Jae-Sook, Park, Jinny, Park, Seonyang, Kim, Inho

“…Background: Droplet digital polymerase chain reaction (ddPCR) is an exact method of measurement. Objectives: We conducted this study to identify the prognostic…”
Get full text